Hot Pursuit     08-Jul-24
Dr Reddys Laboratories Ltd gains for fifth session
Dr Reddys Laboratories Ltd is quoting at Rs 6527.8, up 0.12% on the day as on 12:44 IST on the NSE. The stock is up 26.63% in last one year as compared to a 25.49% gain in NIFTY and a 48.09% gain in the Nifty Pharma.

Dr Reddys Laboratories Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 6527.8, up 0.12% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.14% on the day, quoting at 24289.55. The Sensex is at 79913.8, down 0.1%. Dr Reddys Laboratories Ltd has added around 6.91% in last one month.

Meanwhile, Nifty Pharma index of which Dr Reddys Laboratories Ltd is a constituent, has added around 2.99% in last one month and is currently quoting at 20453.85, down 0.43% on the day. The volume in the stock stood at 90750 shares today, compared to the daily average of 5.82 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 6488.65, down 0.09% on the day. Dr Reddys Laboratories Ltd is up 26.63% in last one year as compared to a 25.49% gain in NIFTY and a 48.09% gain in the Nifty Pharma index.

The PE of the stock is 25.4 based on TTM earnings ending March 24.

Previous News
  Dr Reddys Laboratories Ltd slips for fifth straight session
 ( Hot Pursuit - 02-Jul-25   13:35 )
  Dr Reddys Laboratories to hold board meeting
 ( Corporate News - 24-Jun-25   09:53 )
  Dr Reddys Laboratories allots 10,685 equity shares under ESOP
 ( Corporate News - 23-Jun-25   18:31 )
  Dr Reddys Laboratories allots Equity shares
 ( Corporate News - 16-Jun-25   10:27 )
  Dr Reddys Laboratories Ltd up for third consecutive session
 ( Hot Pursuit - 12-Jun-25   13:05 )
  Dr Reddys Laboratories Ltd soars 0.07%, up for fifth straight session
 ( Hot Pursuit - 09-Jun-25   13:00 )
  Dr Reddys Lab gains on global biosimilar deal with Alvotech
 ( Hot Pursuit - 05-Jun-25   10:10 )
  Alvotech and Dr Reddy's enter into collaboration and license agreement for pembrolizumab
 ( Corporate News - 05-Jun-25   09:20 )
  Dr Reddys Laboratories allots 57,840 equity shares under ESOS
 ( Corporate News - 03-Jun-25   16:28 )
  Dr Reddys Labs' manufacturing facility gets two form 483 observations from US FDA
 ( Hot Pursuit - 26-May-25   09:33 )
  DRL’s USA facility gets 2 observations from USFDA
 ( Hot Pursuit - 19-May-25   08:32 )
Other Stories
  Rajshree Polypack bags Rs 3-cr supply order
  05-Jul-25   16:04
  Power and Instrumentation secures Rs 3-cr work order from Nyati Engineering & Construction
  05-Jul-25   15:06
  RVNL bags Rs 143 cr LoA from Southern Railway for traction system upgrade in Tamil Nadu
  05-Jul-25   13:27
  Dhanlaxmi Bank gross advances rises 17% YoY in Q1 FY26
  05-Jul-25   12:45
  Texmaco Rail secures Rs 36-cr wagon order from TCI
  05-Jul-25   12:12
  Hazoor Multi Projects bags Rs 913-cr solar order from Apollo Green Energy
  05-Jul-25   11:27
  BEML secures $6.23 million export orders
  05-Jul-25   11:04
  Shakti Pumps raises Rs 292.6 crore via QIP; PineBridge, LIC MF among top investors
  05-Jul-25   09:52
  Bank of Maharashtra’s total deposits climb 14% YoY to Rs 3.05 lakh crore in Q1
  04-Jul-25   17:35
  GPT Infraprojects bags supply contract from Bangladesh-based Standard Engineers
  04-Jul-25   16:01
Back Top